Sutimlimab Pharmacokinetics and Pharmacodynamics in Patients with Cold Agglutinin Disease

Sutimlimab, a humanized monoclonal antibody targeting the classic complement pathway, is approved in the United States, Japan, and the European Union for the treatment of hemolytic anemia in adults with cold agglutinin disease. The objectives of this study were to support dose selection for phase 3...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of pharmacology and experimental therapeutics 2023-08, Vol.386 (2), p.143-155
Hauptverfasser:	Frank, Thomas, Kovar, Andreas, Strougo, Ashley, Vage, Chandravathi, Teuscher, Nathan, Wong, Nancy
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!